Koers ViaDerma, Inc. Other OTC
Aandelen
VDRM
US92555K1016
Biotechnologie & Medisch Onderzoek
Omzet 2015 | 192K 177K | Omzet 2016 | 252K 233K | Marktkapitalisatie | 618K 572K |
---|---|---|---|---|---|
Nettowinst (verlies) 2015 | - 0 | Nettowinst (verlies) 2016 | - 0 | EV/omzet 2015 | 1,5 x |
Nettoschuld 2015 | 288K 266K | Nettoschuld 2016 | 297K 274K | EV/omzet 2016 | 3,63 x |
K/w-verhouding 2015 |
10,7
x | K/w-verhouding 2016 |
-3,3
x | Werknemers | - |
Dividendrendement 2015 * |
-
| Dividendrendement 2016 |
-
| Vrij verhandelbaar | 99% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chris Ayo Otiko
CEO | Chief Executive Officer | - | 31-03-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chris Ayo Otiko
CEO | Chief Executive Officer | - | 31-03-14 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,03% | 48,16 mld. | |
-0,10% | 41,73 mld. | |
+43,45% | 41,03 mld. | |
-5,26% | 28,77 mld. | |
+11,48% | 25,59 mld. | |
-22,74% | 18,96 mld. | |
+9,06% | 12,92 mld. | |
+30,01% | 12,03 mld. | |
-1,51% | 11,77 mld. |